UCon is a partially implantable neuromodulation system for urinary and fecal incontinence relief.
UCon is a partially implantable neuromodulation system targeting the dorsal genital nerve to relieve symptoms of urinary and fecal urgency/frequency and leakage (developed for investigational purposes).
Axonics Inc is a United States-based medical technology company. It focuses on developing and commercializing novel products for adults with bladder and bowel dysfunction, that include implantable SNM systems to treat urinary urge incontinence and urinary urgency frequency (UUF); a urethral bulking agent (Bulkamid) to treat female stress urinary incontinence. SNM therapy is predominantly used to treat patients with overactive bladder, fecal incontinence, and urinary retention. Geographically, the company generates majority of its revenue from United States and rest from International markets.
UK-based Livanova was born of a combination between Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions and neuromodulation devices.